AzTrials
AzTrials

OsteoarthritisNCT00405379

Trabecular Metal Mesh Tibial Monoblock RSA

A study testing Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty in people with Osteoarthritis, run by Dalhousie University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Trabecular Metal(TM) is a relatively new technology and its use in knee replacement is quite different from the more conventional total knee replacement (arthroplastie). The aim of incorporating TMM into the material used for the knee replacement (tibial prostheses) is to improve initial fixation of the prosthesis at… Read more about this study

Who is it for?
Ages 55 to 80 years
Conditions the study is for
Osteoarthritis
What is being tested?
Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty
Type of treatment
Medical device
How many people
67 participants
Where
No sites listed yet
Study dates
Jul 2002to Feb 2007
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 55 and 80
  • Primary osteoarthritis of the knee
  • Mono-articular disease (Charnley Modified Type A)

Who cannot join

  • Significant co-morbidity affecting ability to ambulate
  • Flexion contracture greater than 15°
  • Tibial subluxation greater than 10 mm on standing AP radiograph
  • Greater than 10° of varus or 15° of valgus
  • Extension lag greater than 10°
  • Lateral or medial collateral ligament instability (> 10° varus/valgus)
Show all 12Show fewer
  • Previous osteotomy about the knee
  • Previous arthroplasty of the knee
  • Previous patellectomy
  • Posterior cruciate ligament deficiency
  • Leg length discrepancy greater than 10 mm
  • Morbid obesity

About this study

Official title: A Prospective Randomized Controlled Trial Using Roentgen Stereophotogrammetric Analysis of Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty Component "TMM".

Trabecular Metal(TM) is a relatively new technology and its use in knee replacement is quite different from the more conventional total knee replacement (arthroplastie). The aim of incorporating TMM into the material used for the knee replacement (tibial prostheses) is to improve initial fixation of the prosthesis at the time of implantation (surgery) and to improve long term prosthesis survival by encouraging and improving bone ingrowth.

Read the detailed description

Hip and knee replacement arthroplasty are profoundly successful operative interventions, however, some joint replacements do fail and the life expectancy of a hip or knee arthroplasty is finite (Malchau et al. 1993, Knutson et al. 1994, Herberts et al. 1997, Garellick et al. 1998). This fact has largely been responsible for the continued development of new devices and techniques for joint arthroplasty surgery. Unfortunately, the introduction of new technologies and devices is not a benign process, and even subtle changes to existing implants can have a disastrous effect on patient outcome (Sudmann et al. 1983, Herberts P. 1986, Ohlin et al. 1989, Wedderkopp et al. 1997, Howie et al. 1998, Nilsson et al. 1998).

The fact that new technologies and devices can lead to poor results has led some authors to advocate a phased introduction of new technologies (Gross 1988, Gross 1993, Malchau 1999). A key component of the phased introduction approach advocates the use of roentgen stereophotogrammetric analysis (RSA) early in the testing process (Malchau 1999).

RSA is a highly accurate radiographic technique developed in Lund, Sweden and has for some time been the gold standard in Europe for assessing the stability of implants within bone (Selvik 1990, Ryd 1992, Catani et al. 1998, Alfaro-Adrian et al. 1999). It is at least ten times more accurate than conventional radiography (Ryd et al. 1986). RSA involves the insertion of small tantalum markers (0.8mm) into the bone and prosthesis at the time of surgery (Ryd 1986, Ryd et al. 1986, Ryd et al. 1989, Selvik 1990, Ryd 1992). By using a calibrated cage with additional markers and simultaneous bi-planar x-rays, micromotion at the prosthesis-bone interface can be very precisely determined (Selvik et al. 1983). Two types of micromotion can be investigated: migration, i.e. gradual motion over time, and inducible displacement, i.e. instant motion in response to external forces (Ryd et al. 1986). The pattern of micromotion exhibited by various prostheses and fixation techniques within the first post-operative year has been shown to be predictive of the long-term fixation of the component to bone, especially when considering the tibial prosthesis-bone interface (Ryd 1986, Ryd et al. 1986, Ryd 1992, Ryd et al. 1995). The value of this precise radiographic technique is that new technologies and techniques can be introduced in vivo while limiting their exposure to as few patients as possible. RSA is a proven, safe and invaluable method for assessing methods of tibial component fixation as well as different design concepts (Ryd et al. 1987, Nilsson et al. 1991, Ryd et al. 1992, Ryd et al. 1993, Hilding et al. 1995, Onsten et al. 1998, Nilsson et al. 1999).

Until recently, RSA technology has been cumbersome and expensive. However, significant advances have made the system more applicable due to the fact that digitized films are being used, and computer programs have been written and can run on small personal computers that will allow for automatic capture and interpretation of x-ray markers and implants (Vrooman et al. 1998).

Trabecular Metal(TM) is a relatively new technology and its use in tibial knee arthroplasty components represents a significant departure from conventional total knee arthroplasties. TM has a high co-efficient of friction and high affinity for bone ingrowth (Bobyn et al. 1999a, Bobyn et al. 1999b, Hacking et al. 2000), subsequently, the aims of incorporating TMM into tibial prostheses is to improve initial fixation of the tibial prosthesis at the time of implantation and to improve long term prosthesis survival by facilitating bone ingrowth. Such advantages remain, however, theoretical, and have yet to be demonstrated in vivo for total knee arthroplasty. With conventional study techniques, a definitive answer to the effect of the prosthetic design on fixation of the tibial component would require a large number of patients and approximately 10 years of follow-up (Ryd 1992, Ryd et al. 1995). RSA provides a means of accurately assessing the tibial component fixation, both immediate and long term, on a relatively small number of patients within two years of the onset of the study. It is critical at this stage to determine the long-term effect of this design concept on component fixation so that any deleterious effects can be addressed and any advantageous effects can be disseminated to the orthopaedic community.

Conditions
Osteoarthritis
Being tested
Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty
Keywords
arthroplasty, RSA, Osteoarthritis, trabecular metal mesh
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Trabecular Metal Mesh Tibial Monoblock Knee ArthroplastyDevice

    new porous metal tibial component with potential to result in improved bone in-growth and implant integration with proximal tibia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. micromotion of tibial component

    Measured: 2 years postoperative

Secondary outcomes (1)
  1. subjective outcomes measured with health outcome questionnaires sf36, WOMAC

    Measured: 2 years postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2006 (estimated)
  2. Study startJul 2002
  3. Primary completionAug 2006
  4. Study completionFeb 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
67 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00405379
Sponsor's protocol ID
DAL06-02
Other IDs
CDHA-RS/2002-096
Status last verified
Apr 2008
First submitted
28 Nov 2006
Last updated
10 Apr 2008
Results posted
No
Data monitoring committee
No

Publications

  • Astephen Wilson JL, Wilson DA, Dunbar MJ, Deluzio KJ. Preoperative gait patterns and BMI are associated with tibial component migration. Acta Orthop. 2010 Aug;81(4):478-86. doi: 10.3109/17453674.2010.501741.

    PubMed 20809746

Questions about this trial

What is this clinical trial studying?

A study testing Trabecular Metal Mesh Tibial Monoblock Knee Arthroplasty in people with Osteoarthritis, run by Dalhousie University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Apr 2008. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

micromotion of tibial component (time frame: 2 years postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00405379, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in